Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Hydroxy Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel aldol condensation route for obeticholic acid intermediate. High yield, scalable process offering cost reduction in API manufacturing and supply chain reliability.
Patent CN102660624A reveals a dual-bacteria catalytic method for high-purity chiral alpha-hydroxy acids, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN101781200B reveals a green amine transesterification method using ionic liquids, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN118272464A reveals enzymatic synthesis of alpha-hydroxystearic acid. Offers green, high-yield production for reliable ceramide precursor supply chains.
Patent CN111269158A reveals a green dimerization route for alpha-hydroxy acid esters, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Patent CN101974603B reveals a novel NAD-independent enzymatic resolution method for high-purity D-alpha-hydroxybutyric acid, offering significant cost reduction and scalable supply chain solutions.
Novel solvent-free and solution-based processes for alpha-hydroxy amides. Enhances supply chain reliability and reduces manufacturing costs for fungicide intermediates.
Novel green synthesis route for DL-alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone offering high yield and purity for vitamin B5 manufacturing supply chains.
Novel patent CN117567311A offers efficient ceramide preparation with simplified post-treatment and high purity for cosmetic and pharmaceutical applications.
Patent CN109134577B reveals a novel 4-step synthesis for lithocholic acid isomers, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.